The present invention relates to the use of galectin-3 materials and methods for predicting the risk of heart failure in a subject with Acute Coronary Syndrome. The invention further relates to the use of galectin-3 in monitoring the efficacy of treatment for heart failure in a subject with Acute Coronary Syndrome.
展开▼